EBITDA: Income before interest, taxes, depreciation and amortization.
DNA X, Inc. (SONM) had EBITDA of $-1.11M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-20.66M |
|
-- |
|
-- |
|
$5.41M |
|
$-5.41M |
|
$-2.55M |
|
$-7.96M |
|
$-7.96M |
|
$-7.96M |
|
$-7.96M |
|
$-20.66M |
|
$-7.96M |
|
$-5.41M |
|
|
EBITDA |
$-1.11M |
0.72M |
|
0.72M |
|
$-28.58 |
|
$-28.58 |
|
| Balance Sheet Financials | |
$28.91M |
|
-- |
|
$14.99M |
|
$43.90M |
|
$48.03M |
|
-- |
|
$3.83M |
|
$51.85M |
|
$-7.96M |
|
$-7.96M |
|
$-7.96M |
|
1.27M |
|
| Cash Flow Statement Financials | |
$-23.53M |
|
-- |
|
$19.49M |
|
$5.34M |
|
$1.30M |
|
$-4.04M |
|
$1.54M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.60 |
|
-- |
|
-- |
|
-- |
|
-0.64 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.53M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
100.00% |
|
-18.12% |
|
100.00% |
|
$-6.29 |
|
$-32.55 |
|
$-32.55 |
|